Newcomer Lee Nisley 4

4 · Coherus Oncology, Inc. · Filed Jun 9, 2026

AI-generated summary of this filing

Updated Jun 9, 2026

Coherus (CHRS) Director Lee Nisley Receives RSUs & Options

What Happened

Lee Nisley, a director of Coherus Oncology, received two equity awards on 2026-06-05: 30,000 restricted stock units (RSUs) and a 60,000-share derivative award (options). Both grants were reported at $0 acquisition price (typical for compensation awards reported on Form 4). These are grants — not open-market purchases or sales.

Key Details

Transaction date: 2026-06-05; Form 4 filed 2026-06-09 (filed within the two-business-day reporting window).
Awards and amounts: 30,000 RSUs (F1) and 60,000 derivative/option shares (F2), reported at $0.
Vesting/exercise schedule: RSUs vest 100% on the one-year anniversary of June 3, 2026 (i.e., June 3, 2027). The 60,000 option shares become vested and exercisable 100% on June 3, 2027 (per footnotes).
Shares owned after the transaction: not specified in the provided filing excerpt.
Footnotes: F1 explains RSUs convert to one share per RSU upon vesting; F2 states the underlying option shares vest/become exercisable on June 3, 2027.

Context

RSUs convert to actual shares only upon vesting; until then they are a promise of future shares tied to continued service. The derivative award (options) becomes exercisable on the stated vesting date — this is a grant of potential future stock, not an immediate purchase or sale.
These types of awards are common as director compensation and do not, by themselves, indicate an insider buying or selling stock.

Form 4

Period: 2026-06-05

Director

Transactions

Award
Common Stock
[F1]
2026-06-05+30,000→ 30,000 total
Award
Stock Option (Right to Buy)
[F2]
2026-06-05+60,000→ 60,000 total
Exercise: $1.45Exp: 2036-06-05→ Common Stock (60,000 underlying)

Footnotes (2)

[F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.
[F2]The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date.

Signature

/s/ Bryan McMichael, as Attorney-in-Fact for Lee Nisley Newcomer|2026-06-09

1 file